Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VH4524184 + FTC/TAF in Treatment-Naive HIV-1 (INNOVATE)
NCT07202546Phase 2Recruiting
- Sponsor
- ViiV Healthcare
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of VH4524184 in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Feb 2026; status: recruiting.
02
Drugs
VH4524184
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07202546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07202546.